Kymera Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Kymera Therapeutics

01/11/2024 03:40

* Kymera Therapeutics Inc  KYMR.OQ  reported a quarterly
adjusted
loss of 82 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -90 cents.  The mean expectation of
sixteen analysts for the quarter was for a loss of 84 cents per
share. Wall Street expected results to range from $-1.02 to -67
cents per share.
    * Revenue fell 20.9% to $3.74 million from a year ago;
analysts
expected $10.36 million. 
    * Kymera Therapeutics Inc's reported EPS for the quarter was
a
loss of 82 cents​.
    * The company reported a quarterly loss of $62.49 million.
    * Kymera Therapeutics Inc shares had risen by 0.7% this
quarter and gained 87.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 12.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kymera
Therapeutics Inc is 56.00 
This summary was machine generated from LSEG data November 1 at
03:40 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.84          -0.82          Beat
 Jun. 30 2024      -0.68          -0.58          Beat
 Mar. 31 2024      -0.73          -0.62          Beat
 Dec. 31 2023      -0.40          -0.25          Beat